Close
Please login to see all content from The Global Fund's Archive
External Login
Staff Login
Register
By using our website, you agree to our use of cookies as described in
Cookie Policy
.
OK
X
Go to Login page
Hide details
Linked assets
Result Report 2019
Edits - Master
View More
Similar tones
VBE_0253_e.jpg
Vernon and Zama, who lives with HIV, receive care and support at Durban's TB/HIV Care Center for injecting drug users in South Africa.
Like many people who inject drugs in Durban, Vernon Van Wyngaard, 49, is homeless. He makes money either by begging at intersections or through gardening. Zama Nene, 27, also is homeless. She has been injecting drugs since 2011, but last year was diagnosed with HIV, a result of sharing needles. She is matter-of-fact about her life: “I didn't know about the needle sharing thing, but they say that’s why I have AIDS.”
Nationwide, only around 1,500 people receive opioid replacement therapy – a treatment to help wean injecting drug users off heroin by substituting with methadone. But methadone is not recognized in South Africa as an essential medicine and so costs around 30 times more than elsewhere.
For Zama, coming to the center provides a measure of relief from an overwhelmingly hostile environment. She is constantly exposed to the threat and reality of sexual violence made worse by the stigma that comes from drug use and homelessness. She says: “Living on the streets is difficult. The guys using ‘whoonga’ [a street drug that has become widespread in the townships of Durban over the last decade] are the worst – the scariest.”
The Global Fund / Vincent Becker
Add to lightbox
Add to cart
VBE_0253_e.jpg
Description:
Vernon and Zama, who lives with HIV, receive care and support at Durban's TB/HIV Care Center for injecting drug users in South Africa.
Like many people who inject drugs in Durban, Vernon Van Wyngaard, 49, is homeless. He makes money either by begging at intersections or through gardening. Zama Nene, 27, also is homeless. She has been injecting drugs since 2011, but last year was diagnosed with HIV, a result of sharing needles. She is matter-of-fact about her life: “I didn't know about the needle sharing thing, but they say that’s why I have AIDS.”
Nationwide, only around 1,500 people receive opioid replacement therapy – a treatment to help wean injecting drug users off heroin by substituting with methadone. But methadone is not recognized in South Africa as an essential medicine and so costs around 30 times more than elsewhere.
For Zama, coming to the center provides a measure of relief from an overwhelmingly hostile environment. She is constantly exposed to the threat and reality of sexual violence made worse by the stigma that comes from drug use and homelessness. She says: “Living on the streets is difficult. The guys using ‘whoonga’ [a street drug that has become widespread in the townships of Durban over the last decade] are the worst – the scariest.”
The Global Fund / Vincent Becker
Copyright notice:
The Global Fund/Vincent Becker
Unique identifier:
GF2114395
Type:
Image
Editor's rating:
★★★★★★★
Size:
6429px × 4286px 20MB
Purpose / Rating
Editor's rating:
1
2
3
4
5
6
7
Tags
care
HIV
IDU (Injecting Drug User)
key population
methadone substitution therapy
race
results report
Results Report 2019
support
urban poverty
Tasks
Restrictions